Thyroid Antibody Tests: TPO, Thyroglobulin and TSH-Receptor Antibodies
Thyroid antibody tests look for immune proteins directed at thyroid peroxidase, thyroglobulin or the TSH receptor. They can help identify autoimmune Hashimoto’s or Graves’ disease and answer selected pregnancy or thyroid-cancer monitoring questions.
Timeline
- 2026-10-12: Current government, academic medical-center and thyroid-specialty guidance was reviewed for this guide.
- 2026-10-13: The current authoritative sources cited in this guide were reviewed.
Thyroid antibody tests measure autoantibodies: immune proteins directed at parts of the thyroid system. They are different from thyroid function tests. TSH and free T4 show whether hormone regulation is currently underactive, overactive or within the expected range, while antibodies can help identify an autoimmune cause. Clinicians usually select an antibody test after symptoms, examination or hormone results create a specific question. A broad positive panel does not by itself show how well the thyroid works or whether treatment is needed. [1][2][3][4]
Thyroid peroxidase antibody, written TPOAb or anti-TPO, targets an enzyme used in thyroid-hormone production. It is found in most people with Hashimoto’s disease and can also occur in Graves’ disease or people who do not currently have abnormal thyroid function. When hypothyroidism is demonstrated by TSH and free T4, a positive TPOAb supports autoimmune thyroiditis as the cause. The antibody result alone cannot measure the degree of hormone deficiency, explain every symptom or set a thyroid-hormone dose. [1][3][5][6]
Thyroglobulin antibody, or TgAb, targets thyroglobulin, a protein made by thyroid cells. TgAb can support autoimmune thyroid disease, especially Hashimoto’s, but it has another important role after treatment for differentiated thyroid cancer. Antibodies can interfere with laboratory measurement of thyroglobulin, which may be used as a tumor marker after thyroid removal. For that reason, thyroglobulin and TgAb are often interpreted together and ideally followed with consistent methods. TgAb is not itself a general thyroid-cancer screening test. [1][7][8]
TSH-receptor antibodies are most closely associated with Graves’ disease. Laboratories may report TRAb, which can detect antibodies that interact with the TSH receptor, or TSI, a test focused on stimulating activity. Stimulating antibodies act like TSH and drive excess thyroid-hormone production. Some receptor antibodies can block rather than stimulate signaling, which is one reason names and assay purpose matter. In someone with biochemical hyperthyroidism, an appropriate positive receptor-antibody result can help establish Graves’ disease without assuming every overactive thyroid has the same cause. [1][3][4][9]
Positive and negative are not complete interpretations. Autoantibodies may precede hormone changes, persist after thyroid status changes or occur at low levels without current disease. Conversely, some people with clinical autoimmune thyroid disease do not have detectable antibodies on the assay used. Results and reference limits vary among methods, so values from different laboratories should not be treated as a precise trend. The useful question is whether the selected antibody result fits the person’s TSH, free T4, symptoms, examination and imaging when indicated. [1][2][4][6]
Routine repeat testing depends on the antibody and clinical purpose. The American Thyroid Association notes that repeatedly following TPOAb or TgAb is generally not useful for judging development of hypothyroidism or response to thyroid-hormone therapy; TSH and free T4 guide function and dosing. Receptor-antibody levels can have selected uses during Graves’ treatment and pregnancy. TgAb trends can matter in thyroid-cancer follow-up because of their relationship to thyroglobulin measurement. Reordering every antibody without a defined decision can add confusing numbers without changing care. [4][8]
Pregnancy creates a specific reason for clinician-directed testing. TSH-receptor antibodies can cross the placenta, so a person with current or previous Graves’ disease may need TRAb or TSI assessment and coordinated monitoring even after prior thyroid treatment. TPOAb can also influence how clinicians interpret thyroid risk during pregnancy, but a positive result does not justify self-starting thyroid hormone, iodine or supplements. Pregnancy-specific TSH and free-T4 targets, medication choices and fetal assessment belong with obstetric and endocrine care. [4][9]
Before testing, ask which antibody is being ordered and what decision it will inform. The blood draw itself usually requires no special preparation, but disclose all medicines and supplements and follow the laboratory’s instructions. Afterward, review the exact assay, reference interval, TSH and free T4 together. Seek prompt medical care for severe hyperthyroid symptoms such as marked breathing difficulty, chest pain, fainting or confusion rather than waiting for antibody results. Do not alter thyroid medicine or take high-dose iodine based on an antibody flag alone. [1][2][4][6]
Sources
- MedlinePlus — Thyroid Antibody Tests
- NIDDK — Thyroid Tests
- NIDDK — Graves’ Disease
- American Thyroid Association — Thyroid Function Tests
- NIDDK — Hashimoto’s Disease
- Mayo Clinic — Thyroid Peroxidase Antibody Test
- MedlinePlus Medical Encyclopedia — Antithyroglobulin Antibody Test
- American Thyroid Association — Thyroglobulin Assays
- American Thyroid Association — Thyroid Function Tests Brochure